Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT06951100

Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation

Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation — Recruiting • Cardiology / Cardiovascular • NCT06951100.

📅 15 Jun 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT06951100
Start
2025-05-01
Completion
2026-09
ClinicaliQ Trial Snapshot
  • Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation — Recruiting • Cardiology / Cardiovascular • NCT06951100.
  • Study investigates whether heart damage markers in rapid atrial fibrillation patients indicate blocked arteries or heart attack.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The goal of this observational study is to better understand the role of measuring troponin (a protein measured by a blood test) and coronary imaging in patients presenting with rapid atrial fibrillation (AF) The main questions this study aims to answer are: 1. Are patients with a fast, irregular heartbeat (rapid AF) and damage to the heart (myocardial injury) more likely than those without damage to the heart to have blocked heart arteries (obstructive coronary artery disease) 2. Are patients with a fast, irregular heartbeat (rapid AF) and damage to…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Dad thankful charity scan revealed ‘silent’ heart attack
Cardiology / Cardiovascular · BBC Health · 10 Oct 2026
Asymptomatic coronary artery disease can be clinically significant—charity screening identified a blocked artery in a patient without symptoms, prompting necessary intervention Opportunistic…
View brief →
Clinical Brief
Man completes half marathon after two heart attacks
Cardiology / Cardiovascular · BBC Health · 26 Aug 2026
Key Takeaways for Clinical Practice Cardiac rehabilitation and secondary prevention can enable significant functional recovery post-myocardial infarction, with patients potentially returning to…
View brief →
Clinical Brief
Weight-loss jabs will be offered on NHS for people at risk of further heart attacks
Cardiology / Cardiovascular · BBC Health · 31 Mar 2026
GLP-1 receptor agonists (weight-loss jabs) will now be offered on NHS to over 1 million people in England at high cardiovascular risk,…
View brief →
Guideline
2024 ESC Guidelines for the Management of Atrial Fibrillation
Cardiology / Cardiovascular · 30 Mar 2026
Covers AF classification, stroke risk assessment (CHA2DS2-VASc), and bleeding risk (HAS-BLED) • Provides recommendations for rate vs rhythm control strategies • Addresses…
View guideline →
Clinical Brief
Man fears stroke or heart attack due to aspirin shortage
Cardiology / Cardiovascular · BBC Health · 30 Mar 2026
David Slater, 72, says ministers need to step up and sort out issues with the medication. This update is most useful for…
View brief →
Clinical Brief
The children dying in India’s remote tribal heartland
Cardiology / Cardiovascular · BBC Health · 30 Sep 2026
Measles and malaria resurgence in vulnerable populations: At least 32 child deaths in Balaghat district highlight ongoing risks in remote tribal areas…
View brief →